Susquehanna International Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.57M Sell
38,172
-4,837
-11% -$1.21M ﹤0.01% 3344
2025
Q4
$10.4M Sell
43,009
-6,798
-14% -$1.74M ﹤0.01% 2996
2025
Q3
$13.6M Buy
49,807
+13,258
+36% +$3.62M ﹤0.01% 2612
2025
Q2
$9.43M Buy
36,549
+25,821
+241% +$6.16M ﹤0.01% 2912
2025
Q1
$2.4M Sell
10,728
-49,251
-82% -$11.5M ﹤0.01% 5124
2024
Q4
$13.7M Buy
59,979
+3,301
+6% +$795K ﹤0.01% 2268
2024
Q3
$13.8M Buy
56,678
+13,873
+32% +$3.1M ﹤0.01% 2210
2024
Q2
$8.19M Sell
42,805
-3,519
-8% -$714K ﹤0.01% 2751
2024
Q1
$9.17M Buy
46,324
+2,460
+6% +$451K ﹤0.01% 2722
2023
Q4
$7.55M Sell
43,864
-89,116
-67% -$13.7M ﹤0.01% 3037
2023
Q3
$19.7M Buy
132,980
+48,229
+57% +$8.72M ﹤0.01% 1766
2023
Q2
$18.5M Sell
84,751
-63,622
-43% -$14.2M ﹤0.01% 1799
2023
Q1
$32.5M Buy
148,373
+82,090
+124% +$17.8M 0.01% 1253
2022
Q4
$13.8M Buy
66,283
+62,895
+1,856% +$13.8M ﹤0.01% 1880
2022
Q3
$740K Sell
3,388
-20,426
-86% -$4.65M ﹤0.01% 7422
2022
Q2
$4.99M Sell
23,814
-11,186
-32% -$2.38M ﹤0.01% 3194
2022
Q1
$8.49M Buy
35,000
+3,209
+10% +$776K ﹤0.01% 2769
2021
Q4
$8.28M Buy
31,791
+11,118
+54% +$2.88M ﹤0.01% 2984
2021
Q3
$5.45M Sell
20,673
-50,086
-71% -$13.7M ﹤0.01% 3805
2021
Q2
$17.4M Buy
70,759
+44,985
+175% +$9.46M ﹤0.01% 2212
2021
Q1
$5M Buy
25,774
+12,947
+101% +$2.6M ﹤0.01% 3914
2020
Q4
$2.73M Sell
12,827
-20,501
-62% -$4.09M ﹤0.01% 4472
2020
Q3
$5.71M Sell
33,328
-36,128
-52% -$6.67M ﹤0.01% 2884
2020
Q2
$13.3M Buy
69,456
+54,901
+377% +$8.98M ﹤0.01% 1826
2020
Q1
$2.14M Sell
14,555
-20,713
-59% -$3.3M ﹤0.01% 3848
2019
Q4
$5.46M Buy
+35,268
New +$5.08M ﹤0.01% 2860
2019
Q3
Sell
-1,666
Closed -$218K 10727
2019
Q2
$203K Buy
+1,666
New +$185K ﹤0.01% 9095
2018
Q3
Sell
-2,231
Closed -$244K 10070
2018
Q2
$231K Buy
2,231
+29
+1% +$2.93K ﹤0.01% 8340
2018
Q1
$217K Buy
+2,202
New +$208K ﹤0.01% 8195
2017
Q4
Sell
-26,272
Closed -$2.17M 9806
2017
Q3
$2.02M Sell
26,272
-15,716
-37% -$1.2M ﹤0.01% 3886
2017
Q2
$3.27M Buy
41,988
+31,776
+311% +$2.27M ﹤0.01% 3013
2017
Q1
$735K Buy
10,212
+2,512
+33% +$174K ﹤0.01% 5763
2016
Q4
$478K Sell
7,700
-164,706
-96% -$10.1M ﹤0.01% 7087
2016
Q3
$11.2M Buy
172,406
+17,557
+11% +$1.17M 0.01% 1439
2016
Q2
$9.79M Buy
154,849
+1,122
+0.7% +$66.1K 0.01% 1466
2016
Q1
$8.89M Sell
153,727
-39,871
-21% -$2.26M ﹤0.01% 1672
2015
Q4
$10.4M Sell
193,598
-20,633
-10% -$1.16M ﹤0.01% 1705
2015
Q3
$10.9M Buy
214,231
+85,831
+67% +$4.62M ﹤0.01% 1742
2015
Q2
$7.24M Sell
128,400
-85,214
-40% -$5.38M ﹤0.01% 2406
2015
Q1
$15.3M Buy
213,614
+162,492
+318% +$10.6M 0.01% 1467
2014
Q4
$2.87M Sell
51,122
-43,472
-46% -$2.27M ﹤0.01% 3816
2014
Q3
$4.66M Sell
94,594
-71,539
-43% -$3.64M ﹤0.01% 3127
2014
Q2
$8.41M Sell
166,133
-8,336
-5% -$413K ﹤0.01% 2323
2014
Q1
$7.8M Buy
174,469
+98,313
+129% +$4.42M ﹤0.01% 2306
2013
Q4
$3.59M Sell
76,156
-121,494
-61% -$6.15M ﹤0.01% 3391
2013
Q3
$10.4M Sell
197,650
-33,887
-15% -$1.64M 0.01% 1858
2013
Q2
$10.4M Buy
+231,537
New +$11M 0.01% 1744

Other funds holding RMD

Susquehanna International Group's RMD Position: Q1 2026 in Review

Susquehanna International Group reduced its ResMed (RMD) stake by 11% in Q1 2026, selling an estimated $1.21M and leaving 38,172 shares worth $8.57M. The position accounts for ﹤0.01% of the portfolio, ranked #3344.

Susquehanna International Group first reported a position in RMD in Q2 2013 and has held it in 47 quarters since. The position peaked at $32.5M in Q1 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Susquehanna International Group held 38,172 shares of ResMed worth $8.57M as of Q1 2026.
  • Susquehanna International Group sold 4,837 ResMed shares in Q1 2026, an estimated $1.21M.
  • ResMed made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3344 holding.
  • Susquehanna International Group first reported a position in ResMed in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's ResMed position peaked at $32.5M in Q1 2023.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.